Teladoc Health, Inc. (NYSE:TDOC – Get Rating) was the recipient of some unusual options trading activity on Wednesday. Stock investors acquired 31,416 put options on the company. This is an increase of 103% compared to the typical daily volume of 15,513 put options.
Insider Activity at Teladoc Health
In other news, insider Arnnon Geshuri sold 2,398 shares of the firm’s stock in a transaction that occurred on Monday, November 28th. The stock was sold at an average price of $27.35, for a total value of $65,585.30. Following the transaction, the insider now owns 74,317 shares in the company, valued at $2,032,569.95. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In the last three months, insiders have sold 3,925 shares of company stock valued at $105,198. 1.55% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Teladoc Health
A number of large investors have recently added to or reduced their stakes in TDOC. Quadrant Capital Group LLC increased its position in shares of Teladoc Health by 23.3% during the second quarter. Quadrant Capital Group LLC now owns 1,385 shares of the health services provider’s stock valued at $46,000 after purchasing an additional 262 shares during the period. PSI Advisors LLC boosted its holdings in Teladoc Health by 19.3% during the second quarter. PSI Advisors LLC now owns 1,855 shares of the health services provider’s stock valued at $62,000 after purchasing an additional 300 shares in the last quarter. MAI Capital Management grew its stake in shares of Teladoc Health by 5.1% in the 2nd quarter. MAI Capital Management now owns 6,928 shares of the health services provider’s stock valued at $230,000 after purchasing an additional 337 shares during the period. DB Wealth Management Group LLC bought a new position in shares of Teladoc Health during the 1st quarter worth approximately $25,000. Finally, Antonetti Capital Management LLC boosted its stake in Teladoc Health by 36.5% in the 1st quarter. Antonetti Capital Management LLC now owns 1,401 shares of the health services provider’s stock valued at $101,000 after buying an additional 375 shares in the last quarter. Institutional investors own 84.14% of the company’s stock.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on the company. Oppenheimer dropped their price target on Teladoc Health from $55.00 to $45.00 in a research report on Thursday, October 27th. Citigroup cut their price objective on shares of Teladoc Health from $36.00 to $33.00 and set a “neutral” rating for the company in a research report on Tuesday, December 13th. Credit Suisse Group cut their price target on shares of Teladoc Health from $35.00 to $30.00 and set a “neutral” rating for the company in a report on Monday, October 31st. Canaccord Genuity Group lowered their price objective on Teladoc Health from $45.00 to $43.00 in a research report on Friday, October 28th. Finally, KeyCorp began coverage on Teladoc Health in a research report on Thursday, September 15th. They set a “sector weight” rating for the company. One analyst has rated the stock with a sell rating, twenty-two have given a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $48.21.
Teladoc Health Trading Up 0.2 %
Shares of TDOC traded up $0.04 during midday trading on Wednesday, hitting $22.87. 129,376 shares of the stock traded hands, compared to its average volume of 4,294,641. The business’s 50 day moving average price is $27.50 and its two-hundred day moving average price is $31.32. The company has a debt-to-equity ratio of 0.25, a quick ratio of 2.99 and a current ratio of 3.13. Teladoc Health has a 1-year low of $22.76 and a 1-year high of $96.64.
Teladoc Health (NYSE:TDOC – Get Rating) last released its earnings results on Wednesday, October 26th. The health services provider reported ($0.45) EPS for the quarter, beating the consensus estimate of ($0.59) by $0.14. The business had revenue of $611.40 million during the quarter, compared to analyst estimates of $609.45 million. Teladoc Health had a negative net margin of 424.40% and a negative return on equity of 2.47%. Analysts forecast that Teladoc Health will post -1.4 earnings per share for the current year.
Teladoc Health Company Profile
Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Teladoc Health, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Teladoc Health wasn’t on the list.
While Teladoc Health currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
Source: news.google.com
